Clinical and Translational Medicine (Aug 2024)
Integrating radiosensitivity index and triple‐negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple‐negative breast cancer
Abstract
No abstracts available.
Clinical and Translational Medicine (Aug 2024)